Bloomberg headlines out today regarding letters Trump has sent to various drug manufacturers globally. So far we see LLY, PFE, NOVO, ABBV, BING, BMY, NOVN, GILD, AZN, AMGN, JNJ, GSK, MRK, REGN and SANFP.
Trump Letter on Truth Social:
While this headline contains a lot of proposals, we think the Most Favored Nation pricing request is most important given the Administration could push for Medicaid and Medicare to adopt these more stringent pricing mechanisms. Recall, the US already "negotiates" pricing for the top 10 drugs in the Medicare program; however, this would appear to indicate the Administration's desire to negotiate every drug approved for Medicare/Medicaid. It is too soon to determine real impacts to Global Pharma; however, these headlines will persist and put pressure on the sector in both equity and credit markets.
Find more articles and bullets on these widgets:
European yields pulled back Tuesday in a flattening move.
Closing Yields / 10-Yr EGB Spreads To Germany